These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
272 related items for PubMed ID: 4607434
1. Some pharmacological aspects of antimalarial drugs. Botha D. S Afr Med J; 1974 Jun 15; 48(29):1263-5. PubMed ID: 4607434 [No Abstract] [Full Text] [Related]
2. [Drug resistance of Plasmodium falciparum and Plasmodium vivax strains in Cambodia (Cardamone Massif). Morphological characteristics of Plasmodium vivax]. Lapierre J, Coquelin B, Galal AA, Dupouy-Camet J, Faurant C, Tourte-Schaefer C, Ancelle T, Heyer F. Med Trop (Mars); 1984 Jun 15; 44(4):339-49. PubMed ID: 6394948 [Abstract] [Full Text] [Related]
4. Chemotherapy of the drug-resistant malarias. Schmidt LH. Annu Rev Microbiol; 1969 Jun 15; 23():427-54. PubMed ID: 4901983 [No Abstract] [Full Text] [Related]
5. Pharmacokinetics of antimalarial drugs: their therapeutic and toxicological implications. Salako LA. Ann Ist Super Sanita; 1985 Jun 15; 21(3):315-25. PubMed ID: 3914849 [No Abstract] [Full Text] [Related]
6. Malaria. Chemoprophylaxis and chemotherapy. Peters W. Br Med J; 1971 Apr 10; 2(5753):95-8. PubMed ID: 4927912 [No Abstract] [Full Text] [Related]
10. Plasmodium falciparum malaria: rosettes are disrupted by quinine, artemisinin, mefloquine, primaquine, pyrimethamine, chloroquine and proguanil. Goldring JD, Padayachee T, Ismail I. Mem Inst Oswaldo Cruz; 1999 Apr 10; 94(5):667-74. PubMed ID: 10464415 [Abstract] [Full Text] [Related]
11. Prophylactic and sporontocidal treatment of chloroquine-resistant Plasmodium falciparum from Vietnam. Clyde DF, Miller RM, Music SI, McCarthy VC. Am J Trop Med Hyg; 1971 Jan 10; 20(1):1-5. PubMed ID: 4936022 [No Abstract] [Full Text] [Related]
15. Malaria treatment and prevention. A review. Hall SA. East Afr Med J; 1969 Oct 10; 46(10):553-63. PubMed ID: 4905723 [No Abstract] [Full Text] [Related]
16. Recent advances in antimalarial chemotherapy and drug resistance. Peters W. Adv Parasitol; 1974 Oct 10; 12():69-114. PubMed ID: 4217563 [No Abstract] [Full Text] [Related]
17. A clinical view of the biology of Plasmodia. Altstatt LB. Ann Intern Med; 1969 Jan 10; 70(1):130-4. PubMed ID: 4884380 [No Abstract] [Full Text] [Related]
18. A model in vitro system to test the susceptibility of human malarial parasites to antimalarial drugs. Siddiqui WA, Schnell JV, Geiman QM. Am J Trop Med Hyg; 1972 Jul 10; 21(4):393-9. PubMed ID: 4559064 [No Abstract] [Full Text] [Related]
19. The sporogonous of Plasmodium vivax in Anopheles mosquitoes as a system for evaluating the prophylactic and curative capabilities of potential antimalarial compounds. Terzian LA, Stahler N, Dawkins AT. Exp Parasitol; 1968 Aug 10; 23(1):56-66. PubMed ID: 4876903 [No Abstract] [Full Text] [Related]
20. Antimalarial effects of sulphormethoxine, diaphenylsulphone and separate combinations of these with pyrimethamine: a review of preliminary investigations carried out in Tanzania. Laing AB. J Trop Med Hyg; 1968 Feb 10; 71(2):27-35. PubMed ID: 4867507 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]